Coya Therapeutics (COYA) Revenue (2023 - 2026)
Coya Therapeutics (COYA) reported Revenue of $251147.0 for Q1 2026, down 2.61% on a YoY basis from $257884.0 in Q1 2025, and down 93.66% sequentially from $4.0 million in Q4 2025.
Coya Therapeutics (COYA) Revenue (2023 - 2026) Analysis & Trends
Coya Therapeutics (COYA) has 4 years of Revenue data on file, last reported at $251147.0 in Q1 2026.
- For the quarter ending Q1 2026, Revenue fell 2.61% year-over-year to $251147.0; the trailing twelve-month figure through Mar 2026 stood at $7.9 million (up 115.44% YoY), and the FY2025 full-year result was $7.9 million, up 123.57% from the prior year.
- Revenue eased to $251147.0 in Q1 2026, from $4.0 million in the prior quarter.
- In the past five years, Revenue ranged from a high of $6.0 million in Q4 2023 to a low of $1952.0 in Q4 2024.
- A 4-year average of $2.0 million and a median of $257884.0 in 2025 frame the typical range for Revenue.
- Across the five-year window, Revenue slumped 99.97% in 2024 and soared 202768.8% in 2025, its largest moves.
- Tracing COYA's Revenue over 4 years: stood at $6.0 million in 2023, then tumbled by 99.97% to $1952.0 in 2024, then soared by 202768.8% to $4.0 million in 2025, then tumbled by 93.66% to $251147.0 in 2026.
- Business Quant data shows COYA's Revenue at $251147.0 in Q1 2026, $4.0 million in Q4 2025, and $3.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,899.61 Bn | 65,899.33 Bn | - | - |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - | - |
| 3 | Akari Therapeutics | 1,022.34 Bn | 1,022.34 Bn | - | - |
| 4 | BeOne Medicines | 472.68 Bn | 467.89 Bn | 1.35 Bn | 1.51 Bn |
| 5 | Vertex Pharmaceuticals | 122.24 Bn | 114.99 Bn | 2.59 Bn | 2.99 Bn |
| 6 | Regeneron Pharmaceuticals | 70.08 Bn | 61.33 Bn | 3.31 Bn | 3.61 Bn |
| 7 | Belite Bio | 62.46 Bn | 62.46 Bn | - | - |
| 8 | Argenx Se | 55.93 Bn | 50.75 Bn | 1.41 Bn | 1.56 Bn |
| 9 | Alnylam Pharmaceuticals | 37.59 Bn | 34.58 Bn | 959.66 Mn | 1.17 Bn |
| 10 | Coya Therapeutics | 98.05 Mn | 47.33 Mn | - | 251,147.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 251,147.00 |
| Dec 31, 2025 | 3.96 Mn |
| Sep 30, 2025 | 3.56 Mn |
| Jun 30, 2025 | 163,616.00 |
| Mar 31, 2025 | 257,884.00 |
| Dec 31, 2024 | 1,952.00 |
| Jun 30, 2024 | 3.43 Mn |
| Mar 31, 2024 | 126,838.00 |
| Dec 31, 2023 | 6.00 Mn |